Fundraising Fox

Marcelo Bigal

Board director at Ventus Therapeutics

Pennsylvania

Writes $100K – $5M checks · typically $1.5M

Find your path to Marcelo

325 people in our graph share verified history with Marcelo — schools, employers, funds. One of them is your warm intro.

Catherine Pearce, DHSc, MBAunlockedMarcelo: together at Teva Pharmaceuticals (2014–2015)
×5Marcelo: together at Merck
Marcelo: together at Ventus Therapeutics
×3Marcelo: together at USP - Universidade de São Paulo

About

Marcelo Bigal is President and CEO of Ventus Therapeutics, a clinical-stage biopharmaceutical company developing novel medicines in immunology, inflammation, and neurology using structural biology and computational chemistry approaches. He brings over 16 years of pharmaceutical experience spanning R&D, medical, and scientific affairs, including previous roles as Head of R&D, Chief Scientific Officer, and Chief Medical Officer at Teva, and Chief Medical Officer at Labrys, where he led development of fremanezumab, a CGRP monoclonal antibody approved in the US, Canada, and EU. Bigal previously held faculty and research director positions at Albert Einstein College of Medicine and multiple headache research centers, and has authored approximately 330 peer-reviewed publications and edited six neurology textbooks.

Board director at Ventus Therapeutics

Intro paths

→

In turn, Marcelo can intro founders to Ventus Therapeutics's investors below.

Ventus Therapeutics's investors · 9

Andreessen HorowitzMenlo Park · $500K – $50M checks · since 2022Biotechnology Value FundSan Francisco · since 2022Casdin CapitalNew York · since 2022Fonds de solidarité FTQMontreal · since 2021GV (Google Ventures)Mountain View · $250K – $50M checks · since 2020Qatar Investment AuthorityDoha · since 2022RA CapitalBoston · since 2022SoftBank Vision FundLondonVersant VenturesSan Francisco · $250K – $5M checks · since 2022

Co-founders at Ventus Therapeutics

JL
Judith LiebermanCo-Founder

Experience

  1. Ventus TherapeuticsPresident and CEOcurrent2019 — presentMontreal, Canada Area
  2. Vedana TherapeuticsIndependent Board member and Head of the SABcurrent2024 — present
  3. Pacira BioSciences, Inc.Independent Board Member and Chairman of the Science and Technology Committeecurrent2023 — presentUnited States
  4. Santa Ana BioBoard Membercurrent2023 — presentAlameda, California, United States
  5. Versant VenturesVenture Partner2019 — 2023Philadelphia,, PA
  6. CODA BiotherapeuticsBoard Member - Coda Biotherapeutics2019 — 2022
  7. Purdue Pharma L.P.Chief Medical Officer, SVP2018 — 2019United States
  8. Teva PharmaceuticalsHead of Specialty Research and Development & Chief Scientific Officer2017 — 2018
  9. Teva PharmaceuticalsChief Medical Officer & Head of Global Specialty Clinical Development2017Great Valley, PA
  10. Teva PharmaceuticalsHead of Global Specialty Development - Teva Pharmaceuticals2016 — 2017Frazer, PA
  11. Teva PharmaceuticalsSenior Vice President, Head of Clinical Operations & Innovations and TA Head, Migraine & Headaches2015 — 2016Frazer, PA
  12. Teva PharmaceuticalsVice President, Migraine & Headache, Clinical Development R&D at Teva Pharmaceuticals2014 — 2015Frazer, PA
  13. Labrys Biologics, Inc.Chief Medical Officer2013 — 2014Baía de São Francisco e Região, Estados Unidos
  14. MerckHead of the Merck Investigator Study Program, Scientific Engagements and Education2007 — 2013
  15. MerckGlobal Director for Scientific Affairs, Neurology and Psychiatry2007 — 2010Whitehouse Station, PA
  16. Albert Einstein College of MedicineAssociated Professor of Neurology2002 — 2007
  17. The New England Center for HeadacheDirector of Research2002 — 2006Stamford, CT

Skills & more

Pain Management7Research and Development (R&D)4Neurology38Science4Medical Affairs17Emerging Markets4Six Sigma1Migraine11Research Development5Clinical Trials86Drug Development50Pharmacology17
+10 morePharmaceutical IndustryClinical DevelopmentBiotechnologyLifesciencesClinical ResearchHealth EconomicsNeuroscienceLife SciencesManagementheadache management

Languages Potuguese · Spanish

From Marcelo's professional profile.

Frequently asked questions

Who is Marcelo Bigal?
Marcelo Bigal is President and CEO of Ventus Therapeutics, a clinical-stage biopharmaceutical company developing novel medicines in immunology, inflammation, and neurology using structural biology and computational chemistry approaches. He brings over 16 years of pharmaceutical experience spanning R&D, medical, and scientific affairs, including previous roles as Head of R&D, Chief Scientific Officer, and Chief Medical Officer at Teva, and Chief Medical Officer at Labrys, where he led development of fremanezumab, a CGRP monoclonal antibody approved in the US, Canada, and EU. Bigal previously held faculty and research director positions at Albert Einstein College of Medicine and multiple headache research centers, and has authored approximately 330 peer-reviewed publications and edited six neurology textbooks.
Where does Marcelo Bigal work?
Marcelo Bigal is Board director at Ventus Therapeutics.
What check size does Marcelo Bigal write?
Marcelo Bigal typically writes checks of $100K – $5M.
Where did Marcelo Bigal go to school?
Marcelo Bigal studied at New England Center for Headache (Headache Specialist, Headache); USP - Universidade de São Paulo (Ph.D., Neuroscience and Clinicial Sciences); USP - Universidade de São Paulo (MSci, Headaches).

Founder mafias

USP - Universidade de São Paulo mafia58

Also came through, then founded or led a company.

Cristina JunqueiraMaster of ScienceFounded Nubank +1Maria FujiharaMaster's degreeFounded SINAI Technologies Inc. +2Patrick SigristBachelorFounded IORQ +1Matheus RiolfiUndergraduationFounded Tint Technologies +1Saulo TristaoBachelor's degreeFounded FacioHenrique DantasBachelor's degreeFounded Sanctu

+ 51 more

Versant Ventures mafia12

Also came through, then founded or led a company.

Peter EmtageVenture PartnerFounded Santa Ana +1Erik T. EngelsonVenture PartnerFounded Medina Medical +1Mike RosenbluthInvestment ProfessionalFounded Swing +1Rami HannoushVenture PartnerFounded Epi BiologicsBryan BergCBO-in-ResidenceFounded StandardcapBeckie RobertsonManaging DirectorFounded Egis

+ 5 more

Santa Ana Bio mafia3

Also came through, then founded or led a company.

Ansuman SatpathyScientific FounderFounded Santa Ana +3Peter EmtageFounder & CEOFounded Santa Ana

Same school

Also attended USP - Universidade de São Paulo163

Cristina JunqueiraCo-founder of NubankAlexandra DubarInvestor at DaphniMichel AbadiManaging Partner at Maverick Ventures IsraelBruno YoshimuraCo-founder and General Partner at Onevc Venture Partners LlcGustavo RibasInvestor at KfundPaulo VerasInvestor at MatterScale Ventures

+ 157 more

Shared employers

Also worked at Vedana Therapeutics1

Mira ChaurushiyaManaging Director at Westlake Village BioPartners

Also worked at Pacira BioSciences, Inc.5

Ryan KrausVice President at 1315 CapitalScott BraunsteinVice-Chairman of the Board and Director at atai Life SciencesRanice BrownFounder at Magier AIVinay ShahChief Financial Officer at Adial PharmaceuticalsDarren FergusCo-founder & CEO at Profionics

Also worked at Teva Pharmaceuticals39

Catherine Pearce, DHSc, MBAAdvisor at CincyTechElad BaronInvestment Professional at Key1 CapitalElaine ShannonPresident, Global Supply & Quality at Takeda VenturesRiki MozesVice President, Chief People Officer at Jerusalem Venture Partners (JVP)Jill DeSimoneDigital Pharma Advisor at Excelerate Health VenturesPerry NisenExecutive Advisor, Private Equity at Sofinnova Ventures

+ 33 more

Also worked at Labrys Biologics, Inc.1

John BorgesonExecutive Officer at Kodiak Sciences